Clinical Trial: Study of ReCell® Treating for Diabetic Foot Ulcers

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: ReCell® Versus Classic Skin Grafts in Treatment of Diabetic Foot Ulcers: a Comparative Randomized Controlled Trial

Brief Summary: Diabetic foot ulcer is one of the refractory wounds and always poses many challenges in clinical practice. This study was conducted to have a prospective, randomised, controlled study compare the safety and efficacy of the ReCell® technology with skin graft (experiment group) with split-thickness skin graft (STSG, control group) alone on treating diabetic foot ulcers.